Substance P: An inflammatory peptide

European Journal of Inflammation

Volumn 6, Issue 2, 2008, Pages 59-64

  Katsanos, G S ^a   Anogeianaki, A ^a   Orso, C ^a   Tete S ^a   Salini, V ^a   Antinolfi, P L ^b   Sabatino, G ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Cytokines; Neurogenic inflammation; Substance P; T cells

Indexed keywords

ALPHA CHEMOKINE; ANTINEOPLASTIC AGENT; APREPITANT; INTERLEUKIN 8; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA;

ACUPUNCTURE; ASTHMA; ATOPIC DERMATITIS; CENTRAL NERVOUS SYSTEM DISEASE; CYTOKINE PRODUCTION; DRUG METABOLISM; EDITORIAL; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; MACROPHAGE FUNCTION; MAST CELL; MENOPAUSE; NAUSEA AND VOMITING; NEUROGENIC INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SLEEP DISORDER; STRESS; WOUND;

EID: 52149088568     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X0800600202     Document Type: Editorial

References (56)

1. Abbas AK, Lichtman AH. Cellular and Molecular Immunology. Elsevier Saunders Fifth Edition, Philadelphia 2005.
2. Allavena P, Sica A, Garlanda C, Mantovani A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev 2008; 222:155-61.
3. Weiner HL. A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J Neurol 2008; 255(S1):3-11.
4. Castellani ML, Bhattacharya K, Tagen M, Kempuraj D, Perrella A, De Lutiis M, Boucher W, Conti P, Theoharides TC. Anti-chemokine therapy for inflammatory diseases. Int J Immunopathol Pharmacol 2007; 20:447-453.
5. Di Lorenzo L, Vacca A, Corfiati M, Lovreglio P, Soleo L. Evaluation of tumor necrosis factor-alpha and granulocyte colony-stimulating factor serum levels in lead-exposed smoker workers. Int J Immunopathol Pharmacol 2007; 20:239-247.
6. Papoff P, Mancuso M, Barbàra CS, Moretti C. The role of terlipressin in pediatric septic shock: a review of the literature and personal experience. Int J Immunopathol Pharmacol 2007; 20:213-222.
7. Martin AL, Schwartz MD, Jameson SC, Shimizu Y. Selective regulation of CD8 effector T cell migration by the p110gamma isoform of phosphatidylinositol 3-kinase. J Immunol. 2008; 180(4):2081-8.
8. Ou R, Zhang M, Huang L, Flavell RA, Koni PA, Moskophidis D. Regulation of immune response and inflammatory reactions against viral infection by VCAM-1. J Virol 2008; 82(6):2952-65.
9. Rosati E, Mencarelli S, Magini A, Sabatini R, Tassi C, Orlacchio A, Coaccioli S, Frenguelli A, Marconi P, Emiliani C. Enhancement of lysosomal glycohydrolase activity in human primary B lymphocytes during spontaneous apoptosis. Int J Immunopathol Pharmacol 2007; 20:279-288.
10. Hauswirth AW, Sonneck K, Florian ST, Krauth MT, Böhm A, Sperr WR, Valenta R, Schernthaner G-H, Printz D, Fritsch G, Bühring H-J, Valent P. Interleukin-3 promotes the expression of enpp3/cd203c on human blood basophils in healthy subjects and in patients with birch pollen allergy. Int J Immunopathol Pharmacol 2007; 20:267-278.
11. Madonna R, Massaro M, Pandolfi A, Consoli A, Caterina RD. The prominent role of p38 mitogen-activated protein kinase in insulin-mediated enhancement of VCAM-1 expression in endothelial cells. Int J Immunopathol Pharmacol 2007; 20:539-555.
12. Galkina E, Ley K. Leukocyte influx in atherosclerosis. Curr Drug Targets 2007; 8(12):1239-48.
13. Bell LV, Else KJ. Mechanisms of leucocyte recruitment to the inflamed large intestine: redundancy in integrin and addressin usage. Parasite Immunol 2008; 30(3):163-70.
14. D'Offizi G, Gioia C, Corpolongo A, Martini F, Paganelli R, Volpi I, Sacchi A, Tozzi V, Narciso P, Poccia F. An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjects. Int J Immunopathol Pharmacol 2007; 20:473-485.
15. Ventura MT, Sanapo F, Calogiuri GF, Satriano F. Anaphylaxis induced by intramuscular betamethasone disodium phosphate: reflections on a clinical case. Int J Immunopathol Pharmacol 2007; 20:387-392.
16. Feliciani C, Ruocco E, Zampetti A, Toto P, Amerio Pa, Tulli A, Amerio P, Ruocco V. Tannic acid induces in vitro acantholysis of keratinocytes via IL-1α and TNF-α. Int J Immunopathol Pharmacol 2007; 20: 289-300.
17. Mayerhofer M, Aichberger KJ, Florian S, Valent P. Recognition-sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense. Int J Immunopathol Pharmacol 2007; 20:421-434.
18. Leeman SE, Ferguson SL. Substance P: an historical perspective. Neuropeptides 2000; 34(5):249-54.
19. Boyd ND, MacDonald SG, Kage R, Luber-Narod J, Leeman SE. Substance P receptor. Biochemical characterization and interactions with G proteins. Ann NY Acad Sci. 1991; 632:79-93.
20. Anisman H, Baines MG, Berczi I, et al. Neuroimmune mechanisms in health and disease: 1. Health. CMAJ 1996; 155(7):867-74.
21. Luger TA, Bhardwaj RS, Grabbe S, Schwarz T. Regulation of the immune response by epidermal cytokines and neurohormones. J Dermatol Sci 1996; 13(1):5-10.
22. Sluka KA. Pain mechanisms involved in musculoskeletal disorders. J Orthop Sports Phys Ther 1996; 24(4):240-54.
23. Chancellor-Freeland C, Zhu GF, Kage R, Beller DI, Leeman SE, Black PH. Substance P and stress-induced changes in macrophages. Ann NY Acad Sci 1995; 771:472-84.
24. Cohen PA, Gower AC, Stucchi AF, Leeman SE, Becker JM, Reed KL. A neurokinin-1 receptor antagonist that reduces intraabdominal adhesion formation increases peritoneal matrix metalloproteinase activity. Wound Repair Regen 2007; 15(6):800-8.
25. Karagiannides I, Kokkotou E, Tansky M, Tchkonia T, Giorgadze N, O'Brien M, Leeman SE, Kirkland JL, Pothoulakis C. Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes. Proc Natl Acad Sci USA 2006; 103(13):5207-12.
26. Misery L. Neuro-immuno-cutaneous system (NICS). Pathol Biol (Paris) 1996; 44(10):867-74.
27. Staniek V, Misery L. Substance P and human skin. Pathol Biol (Paris) 1996; 44(10):860-6.
28. Caddell JL. Evidence for magnesium deficiency in the pathogenesis of bronchopulmonary dysplasia (BPD). Magnes Res 1996; 9(3):205-16.
29. Paulus WJ. Paracrine coronary endothelial modulation of diastolic left ventricular function in man: implications for diastolic heart failure. J Card Fail 1996; 2(4S):155-64.
30. Koon HW, Pothoulakis C. Immunomodulatory properties of substance P: the gastrointestinal system as a model. Ann NY Acad Sci. 2006; 1088:23-40.
31. Zhu W, Mantione KJ, Kream RM, Cadet P, Stefano GB. Cholinergic regulation of morphine release from human white blood cells: evidence for a novel nicotinic receptor via pharmacological and microarray analysis. Int J Immunopathol Pharmacol 2007; 30:229-238.
32. Lavagno L, Ferrero E, Ortolan E, Malavasi F, Funaro A. CD157 is part of a supramolecular complex with CD11b/CD18 on the human neutrophil cell surface. J Biol Regul Homeost Agents 2007; 21:5-12.
33. Santagostino A, Saggia C, Migliora P et al. Prospective study on prognostic significance of DNA ploidy and Ki-67 expression in colorectoral cancer. J Biol Regul Homeost Agents 2007; 21:13-22.
34. Kingsley CI, Nadig SN, Wood KJ. Transplantation tolerance: lessons from experimental rodent models. Transpl Int 2007; 20(10):828-41.
35. Bocchietto E, Paolucci C, Breda D, Sabbioni E, Burastero SE. Human monocytoid THP-1 cell line versus monocyte-derived human immature dendritic cells as in vitro models for predicting the sensitising potential of chemicals. Int J Immunopathol Pharmacol 2007; 20: 259-266.
36. Garbuglia AR, Grasso F, Donà MG, Mochi S, Conti P, De Lutiis MA, Giorgi C, Iezzi T. TTV infection: role of IFNs, IL-28 and IL-29 cytokines, antiviral proteins. Int J Immunopathol Pharmacol 2007; 20: 249-258.
37. Ikeda Y, Takei H, Matsumoto C, Mase A, Yamamoto M, Takeda S, Ishige A, Watanabe K. Administration of substance P during a primary immune response amplifies the secondary immune response via a long-lasting effect on CD8+ T lymphocytes. Arch Dermatol Res 2007; 299(7):345-51.
38. Shim JY, Han Y, Ahn JY, Yun YS, Song JY. Chemoprotective and adjuvant effects of immunomodulator ginsan in cyclophosphamide-treated normal and tumor bearing mice. Int J Immunopathol Pharmacol 2007; 20:487-497.
39. Kalish RS. Clues from alopecia areata on the role of neuropeptides in the initiation of autoimmunity. J Invest Dermatol 2007; 127(6):1489-97.
40. Chung KF. Effects of nedocromil sodium on airway neurogenic mechanisms. J Allergy Clin Immunol 1996; 98:S112-6.
41. Thomson LM, Terman GW, Zeng J, Lowe J, Chavkin C, Hermes SM, Hegarty DM, Aicher SA. Decreased substance P and NK1 receptor immunoreactivity and function in the spinal cord dorsal horn of morphine-treated neonatal rats. J Pain 2008; 9(1):11-9.
42. Caudle RM, Mannes AJ, Keller J, Perez FM, Suckow SK, Neubert JK. Sensitization of spinal cord nociceptive neurons with a conjugate of substance P and cholera toxin. BMC Neurosci 2007; 10:8:30.
43. Gelardi M, Maselli del Giudice A, Fiorella ML, Soleti P, Di Gioacchino M, Conti CM, Fulcheri M, Doyle R, Ciprandi G. Quality of life in non-allergic rhinitis depends on the predominant inflammatory cell type. J Biol Regul Homeost Agents 2007; 22: 73-81.
44. Speranza L, Grilli A, Patruno A et al. Plasmatic markers of muscular stress in isokinetic exercise. J Biol Regul Homeost Agents 2007; 21:23-32.
45. Deepak P, Kumar S, Acharya A. IL- 13 neutralization modulates function of type II polarized macrophages in vivo in a murine T-cell lymphoma. Eur J Inflamm 2007; 5:37-46.
46. Liu D, Jiang LS, Dai LY. Substance P and its receptors in bone metabolism. Neuropeptides. 2007; 41(5):271-83.
47. Ventura MT, Gelardi M, Di Gioia R, Buquicchio R, Accettura G, Tummolo RA, Arsioni A. Statistical evaluation and parameters of phlogosis in patients sensitized to cypress. J Biol Regul Homeost Agents 2007; 21:41-47.
48. Pollice R, Tomassini A, Malavolta M, Di Giovambattista E, Verni L, Roncone R, Conti CM, Casacchia M. Subjective and psychopathological response in patients under different antipsychotic treatments: are there differences in real clinical practice? J Biol Regul Homeost Agents 2007; 22: 83-91.
49. Sohn SJ. Substance P upregulates osteoclastogenesis by activating nuclear factor kappa B in osteoclast precursors. Acta Otolaryngol 2005; 125(2):130-3.
50. Lin Q, Li D, Xu X, Zou X, Fang L. Roles of TRPV1 and neuropeptidergic receptors in dorsal root reflex-mediated neurogenic inflammation induced by intradermal injection of capsaicin. Mol Pain 2007; 3: 30-39.
51. Anogianaki A, Negrev NN, Shaik YB et al. Capsaicin: an irritant anti-inflammatory compound. J Biol Regul Homeost Agents 2007; 21:1-4.
52. Cadoni S, Ruffelli M, Fusari S, de Pità O. Oral allergic syndrome and recombinant allergens rBet v 1 and rBet v 2. Eur J Inflamm 2007; 5:21-26.
53. Ciprandi G, Cirillo I, Troisi RM, Marseglia GL. Allergic subjects have more numerous respiratory infections and severe gastrointestinal infections than non-allergic subjects: preliminary results.. Eur J Inflamm 2007; 5:27.
54. Pannone G, Sanguedolce F, De Maria S, et al. Cyclooxygenase isozymes in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations. Int J Immunopathol Pharmacol 2007; 20:317-324.
55. Ro JY, Zhang Y, Nies M. Substance P does not play a critical role in neurogenic inflammation in the rat masseter muscle. Brain Res 2005; 1047(1):38-44.
56. Madsen JL, Fuglsang S.A randomized, placebo-controlled, crossover, double-blind trial of the NK1 receptor antagonist aprepitant on gastrointestinal motor function in healthy humans. Aliment Pharmacol Ther 2008; 27:609-15.